DCLK1 and colorectal adenocarcinoma: To assess whether DCLK1-mediated alteration in β-catenin correlated with clinical activity, we first analyzed the TCGA database for β-catenin mRNA expression levels in HCC, cholangiocarcinoma, and colorectal adenocarcinoma.